Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 4 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $181.8K in total
- 4
- Insider sellsLast 90 days, $504.8K in total
- 3
- 13F holdersQ2 2026, −3 vs. previous quarter
- 5
- 13F valueReported value at the end of Q2 2026
- $338.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SHPH, Q2 2026
No superinvestor reported holding SHPH at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Shuttle Pharmaceuticals Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 (view filing)3:36 PM ET | Jul 13-14 | 2 days | HRT Financial LP10% Owner | SSale | −83.1K | $4.48 | −$372.7K | −100.0%0 after | 2 lots |
| Jul 13, 2026 (view filing)2:34 PM ET | Jul 9-10 | 4 days | HRT Financial LP10% Owner | PPurchase | +9.00K | $3.36 | +$30.2K | +17.2%61.3K after | 2 lots |
| Jul 9, 2026 (view filing)5:50 PM ET | Jul 7-8 | 2 days | HRT Financial LP10% Owner | SSale | −29.1K | $3.45 | −$100.5K | −35.8%52.3K after | 2 lots |
| Jul 7, 2026 (view filing)4:23 PM ET | Jul 2 | 5 days | HRT Financial LP10% Owner | PPurchase | +7.85K | $3.54 | +$27.8K | +9.5%90.4K after | |
| Jul 7, 2026 (view filing)4:23 PM ET | Jul 6 | 1 day | HRT Financial LP10% Owner | SSale | −9.02K | $3.51 | −$31.7K | −10.0%81.4K after | |
| Jul 2, 2026 (view filing)1:37 PM ET | Jul 1 | 1 day | HRT Financial LP10% Owner | PPurchase | +3.96K | $3.30 | +$13.1K | +5.0%82.6K after | |
| Jul 1, 2026 (view filing)7:17 PM ET | Jun 29-30 | 2 days | HRT Financial LP10% Owner | PPurchase | +32.6K | $3.40 | +$110.7K | +70.8%78.6K after | 2 lots |
| Mar 14, 2024 (view filing) | Dec 29, 2022 | 441 daysLate | Senanayake ChrisDirector | SSale | −1.63K | $1.61 | −$2.62K | −36.8%2.79K after | |
| Jan 2, 2024 (view filing)5:10 PM ET | Dec 13, 2023 | 20 daysLate | Brown MiltonDirector | SSale | −2.92K | $0.4632 | −$1.35K | −0.3%1.09M after | |
| Dec 20, 2023 (view filing)9:51 PM ET | Dec 13 | 7 daysLate | Jacobs BetteDirector | SSale | −4.16K | $0.4632 | −$1.93K | −13.3%27.1K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Shuttle Pharmaceuticals Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 78,597 | $255.0K | 0.00% | +78,597 | New |
| Citadel Advisors LLC | 24,354 | $79.2K | 0.00% | +24,354 | New |
| Barclays PLC | 750 | $2.44K | 0.00% | +750 | New |
| Tower Research Capital LLC (TRC) | 389 | $1.26K | 0.00% | −4,252−91.6% | Reduced |
| Wall Street Access Asset Management, LLC | 120 | $390 | 0.00% | −480−80.0% | Reduced |